- Sinusoidal obstruction syndrome induced by monocrotaline in a large animal experiment - a pilot study2018 | Faculty of Medicine in Pilsen
- Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome2020 | Faculty of Medicine in Pilsen
- A Critical Analysis of Experimental Animal Models of Sinusoidal Obstruction Syndrome2019 | Faculty of Medicine in Pilsen
- Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation2018 | Second Faculty of Medicine
- Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party2021 | Publication without faculty affiliation
- Biliary obstruction following transjugular intrahepatic portosystemic shunt placement in a patient after liver transplantation: A case report +1Publication without faculty affiliation
- Transjugular Intrahepatic Portosystemic Shunt in Liver Transplant Recipients: Outcomes in Six Adult Patients2023 | Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)2020 | Second Faculty of Medicine
- Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial2022 | Second Faculty of Medicine
- GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study2017 | Second Faculty of Medicine
- Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus2016 | Publication without faculty affiliation
- A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)2021 | Second Faculty of Medicine